Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05660070 · ClinicalTrials.gov registry record · NA
Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05660070: Completed NA study, sponsored by University of California, San Diego.
NCT05660070 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05660070, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This open trial will test a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets social engagement in consumers with serious mental illness.
Primary Outcome
EMA is a method of remote data collection that involves repeatedly sampling a participant's current behaviors, thoughts, mood, and experiences in real time, in their natural environments. The primary outcome in this study will be the number of social interactions.
Interventions
- BEHAVIORAL mobile Social Interaction Therapy by Exposure (mSITE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2024-09-06 |
| Phase | NA |
What the finished NCT05660070 record still lists
NCT05660070 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which mobile Social Interaction Therapy by Exposure (mSITE) is the first listed.
NCT05660070 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05660070 about?
NCT05660070 is a clinical study titled "Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness". This open trial will test a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets social engagement in consumers with serious mental illness.
What is the current status of trial NCT05660070?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-07-01. Estimated completion is 2024-09-06.
What interventions are being tested in trial NCT05660070?
The interventions under investigation include: mobile Social Interaction Therapy by Exposure (mSITE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05660070?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05660070's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI